Association of race and gender with HIV-1 RNA levels and immunologic progression

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 3, 2000, Pages 218-226

  Anastos, Kathryn ^a   Gange, Stephen J ^b   Lau, Bryan ^b   Weiser, Barbara ^e,f   Detels, Roger ^c   Giorgi, Janis V ^d   Margolick, Joseph B ^b   Cohen, Mardge ^f   Phair, John ^a   Melnick, Sandra ^g   Rinaldo, Charles R ^h   Kovacs, Andrea ⁱ   Levine, Alexandra ⁱ   Landesman, Sheldon ^j   Young, Mary ^k   Muñoz, Alvaro ^b   Greenblatt, Ruth M ^l  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WADSWORTH CENTER   (United States)

^f Jr Hospital of Cook County   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j SUNY DOWNSTATE MEDICAL CENTER   (United States)

^k GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

CD4 cell count; Gender; HIV; Race; Viral load

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VIRUS LOAD;

EID: 0034232826     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200007010-00004     Document Type: Article

References (52)

1. United States Centers for Disease Control and Prevention. Midyear Edition
2. Characteristics of Persons Living with AIDS, United States Centers for Disease Control, at the end of 1997
3. Trends in HIV incidence among young adults in the United States
4. Scope of the AIDS Epidemic in the United States
5. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
6. + lymphocytes as prognostic markers of HIV-1 infection
7. + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
8. Immunity during pregnancy: Lymphocyte subpopulations and mitogen responsiveness
9. Functional aspects of T-lymphocyte subsets during pregnancy
10. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men
11. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers
12. Serum levels of virus burden in early-stage human immunodeficiency virus type I disease in women
13. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
14. Gender differences in antiretroviral therapy received in Ontario: A possible effect of viral load differences
15. Sex differences in HIV-1 viral load and progression to AIDS
16. Comparisons of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups
17. Sex differences in HIV-1 viral load and progression to AIDS
18. Sex differences in HIV-1 viral load and progression to AIDS. ICONA Study Group. Italian cohort of HIV-I positive individuals
19. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
20. Human immunodeficiency virus RNA levels in US adults: A comparison based upon race and ethnicity
21. The Women's Interagency HIV Study (WIHS)-Design, methods, sample, cohort characteristics and comparison with reported AIDS cases in U.S. women
22. National Institute of Allergy and Infectious Diseases, Division of AIDS. Guidelines for flow cytometric immunophenotyping
23. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants
24. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study
25. Effect of anticoagulant, processing delay, and assay method (bDNA, RT-PCR) on measurement of HIV-1 RNA levels in plasma
26. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experience
27. Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the Amplicor HIV Monitor Test
28. Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: Reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology utilization for HIV-1 blood evaluation and standardization in pediatrics
29. Models for the incubation period of AIDS and variations according to age and period
30. Clinical trials using HIV-1 RNA-based primary endpoints; statistical analysis and potential biases
31. Selection by indication of potent antiretroviral therapy usage in a large cohort of HIV-infected women
32. Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia
33. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio
34. Racial differences in rate of CD4 decline in HIV-1-infected homosexual men
35. Health care delivery, zidovudine use, and survival of women and men with AIDS
36. Survival differences in patients with AIDS
37. Survival for women and men with AIDS
38. Survival and disease progression according to gender of patients with HIV infection
39. Race, sex, drug use, and progression of human immunodeficiency virus disease
40. HIV disease progression in 854 women and men infected through injecting drag use and heterosexual sex and followed for up to nine years from seroconversion
41. Survival with the acquired immunodeficiency syndrome: Experience with 5,833 cases in New York City
42. Do gender differences in CD4 cell counts matter?
43. Immune cell circulating subsets are affected by gonadal function
44. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro
45. Estrogen modulates the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocyte THP-1 cells
46. HLA and HIV-1: Heterozygote advantage and B(*)35-Cw(*)04 disadvantage
47. Postmenopausal hormone replacement: Effects on autonomic, neuroendocrine and immune reactivity to brief psychological stressors
48. + cell counts persist after HIV-1 infection
49. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes
50. Optimization of specimen-handling procedures for accurate quantitation of levels of human irnmunodeficiency virus RNA in plasma by reverse transcriptase PCR